Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/37096
Title: JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.
Authors: 
Keywords: 
Issue Date: 2-Jul-2018
Citation: J. Clin. Invest..2018 Jul;(128)7:3041-3052
Abstract: Monogenic IFN-mediated autoinflammatory diseases present in infancy with systemic inflammation, an IFN response gene signature, inflammatory organ damage, and high mortality. We used the JAK inhibitor baricitinib, with IFN-blocking activity in vitro, to ameliorate disease.
PMID: 29649002
URI: https://hdl.handle.net/20.500.12530/37096
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos
Hospitales > H. U. La Paz > Artículos

Files in This Item:
File Description SizeFormat 
PMC6026004.pdf6.96 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.